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Objectives: To evaluate the role of intraoperative an-
eurysm sac embolization during EVAR (edEVAR) with
coils and glue, in the prevention of Endoleak type II (ET2).
Methods: Two groups were compared: 85 patients under-
went standard EVAR during 2007-2008 (Group A) and 81
patients underwent edEVARduring2009-2010 (GroupB).CT
scans were elaborated with the Osirix 4.0 software in order to
obtain aneurysm sac volume. ET2 rates at the first CT scan
follow-up, as mid-term free from ET2 and free from related
reintervention were compared. Preoperative patent number of
aortic side branches (IMA, lumbars, accessories renal), thrombus
and sac volume were evaluated for their association with ET2 in
the two groups, using multivariate analysis.
Results: Patients characteristics, Society for Vascular
Surgery (SVS) comorbidity score (0.850.44 vs
0.820.48; P  .68) and operative time (185.451.8 vs
172.950.8;P .99) were similar between group A and B.
The first CT scan (or  2 months) demonstrated signif-
icantly higher number of ET2 in group A compared to
group B (23.5% vs 9.8%;P  .02). Spontaneous ET2 reso-
lution occurred in 65% of patients in Group A and 79% in
group B (P  1.0), while sac volume increased in 25% vs
10% (P .63) of cases respectively. At 18 months (range:6
to 24) overall mean difference in sac volume shrinkage
(27.212.3 cm3 vs 24.811.6 cm3; P  .19) and free
from ET2 (91.8% vs 96.3%; P  0.33) were similar, while
free from reintervention was significantly lower in Group A
(94.1% vs 98.8%; P  .05) compared to Group B. Multi-
variate analysis showed preoperative aneurysm sac volume
 125 cm3 to be the only independent significant predictor
of ET2 (OR, 3.64; 95% CI, 1.54 to 8.58; P  .003).
Conclusions:EdEVAR seems to be a valid approach to
prevent ET2 and its complications during short and mid-
term follow-up. Patients with preoperative aneurysm sac
volume higher than 125 cm3 should be considered for a
more aggressive intraoperative embolization.
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Objectives: Alvimopan is a peripherally acting mu-opioid
antagonist used to shorten the time to return of gastrointestinal
function after surgery. Randomized clinical trials have demon-
strated a shorter time period to return of bowel function and
discharge in open abdominal colonic surgeries, but nodata exists
on its use in the aortic vascular surgery population.
Methods: Alvimopan was administered to patients hav-
ing open abdominal aortic aneurysm repair or aortofemoral
bypass. The administration protocol was one 12 mg dose
preoperatively and doses of 12mg twice a day postoperatively
until the first bowel movement or a total of seven days. There
were seven patients in the study group and 6 patients in the
control group. The primary end points were time to regain
bowel function and length of hospital stay.
Results: The average age (Study  69.3  3.8 years vs.
Control 68.5 3.4 years; P  .88), abdominal aortic aneu-
rysm size (Study 5.9 0.3 cm vs. Control 5.3 0.5 cm;P
 .28), procedure time (Study2.10.1 hours vs. Control
2.6 0.3 hours;P .12), gender and comorbidities were not
different between the two cohorts. There is a quicker time to
regain bowel function (Study 2.9 0.4 days vs. Control
4.5  0.6 days; P  .04) and shorter hospitalization (Study
5.60.3days vs.Control6.80.4days;P .03) in the
study group compared to the control group.
Conclusions: These preliminary data show that peri-
operative Alvimopan benefits patients, resulting in quicker
time to regain bowel function and shorter hospitalization,
consistent with previous studies involving open abdominal
bowel resection. This improved resource utilization sup-
ports further investigation via a large scale randomized
pharmacoeconomic endpoint trial.
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Objectives: Aortic coarctation is one of themost common
congenital aortic lesionsand isusually repaired inearlychildhood.
Without correction, death often occurs before the fourth decade
and surviving adults suffer from hypertension and other compli-
cations from poor distal flow.We report on our experience with
open repair of aortic coarctation in adults.
Methods:We retrospectively reviewed all patients age16
years requiring open repair (de novo and redo) of aortic coarcta-
tion.Ourprotocol for spinal cordprotection includesdistal aortic
perfusionvia atriofemoral bypass,moderatepassivehypothermia,
and cerebrospinal fluid drainage. Indications for repair, operative
details, and outcomes were analyzed.
Results: Between 1999 and 2011, we treated 30 patients
withadult aortic coarctation.Themedianagewas40years (range
17-69) and there were 16 males. Eight patients had previous
repair with recurrence; 22 patients had native coarctation. Aortic
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aneurysmwas present in 20 patients (67%), ranging in size from
2.6-9.6 cm. The most common repair was resection of aortic
coarctationwith interposition graft replacement (n26).Other
repairs included bypass from proximal descending thoracic aorta
to the infrarenal aorta (n2); andascending, arch, andproximal
descending aortic replacement via median sternotomy (n 2).
Complications occurred in 7 patients (23%), including chylous
effusion (n 2), recurrent laryngeal nerve injury (n 1), acute
renal failure (n 1), respiratory failure (n 1), atrial fibrillation
(n1), andurinary tract infection (n1). In-hospitalmortality
was 0%.Therewere no cases of immediate or delayed neurologic
deficit. Death occurred in 3 patients during follow-up (mean 19
months, range 1-231); none were related to coarctation repair.
One patient (3%) required reoperation 6 years later due to aneu-
rysm formation distal to the initial repair.
Conclusions: Open repair of adult aortic coarctation has
acceptable morbidity, low mortality, and excellent durability.
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Objectives: To identify trends in EVAR utilization and
outcomes over a 5 year period in a nationwide data set.
Methods: The Nationwide Inpatient Sample database
was queried for the years 2005 to 2009. Number of EVAR
cases, ratio of EVAR/Open repair (OR), major clinical
outcomes, hospital costs and discharge status were analyzed
by decade. Interval data were compared with ANOVA and
proportions via chi squared tests.
Results: There were 174,714 AAA repairs (124,869
EVAR) identified. The ratio of EVAR/OR increased with in-
creasing age. Between the years of 2005 and 2009, the number
of AAA repairs in the elderly increased by 21% (7179 vs. 8554)
and EVAR in patients 80 increased by 50% (5057 vs. 7650
P.05).In 2009 85% of AAA repairs in patients over 80 were
EVAR. 25% of all EVAR cases were performed in age 80
patients.
In hospital mortality rate, remained acceptable in all age
groups.EVARassociatedmortality, lengthof stay, hospital costs,
anddischarge to skillednursing facilities associated increasedwith
each successive decade of life (P.05). Post operative MI and
acute renal failure also increased with increasing age (P.05).
Results of EVAR by decade are presented below.
Conclusions: One quarter of all EVAR cases are being
performed in patients 80 with overall low mortality rates.
There is an age dependent increase in death, complications,
hospital costs and discharge to extended care facilities. Such
factors, and long term aneurysm related death, should be
considered when evaluating the appropriateness of elective
aneurysm repair in the elderly.
Table.
Age group
60–69
years
70–79
years
80–89
years
90
years
Number of patients 33,629 56,783 32,493 1,964
In-hospital mortality .46% .70% 1.56% 2.49%
Average length of stay 2.7 3.1 3.6 4.6
Myocardial infarction 3.69% 4.19% 4.81% 8.41%
Acute renal failure 1.21% 1.92% 2.87% 4.0%
Average hospital cost $26,399 $27,350 $28,490 $30,741
Discharge to SNF 2.19% 5.21% 11.12% 22.29%
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Objectives: Intra-thoracic subclavian artery aneurysms
(SAAs) are rare aneurysms that often occur in association
with concomitant aortic pathology.Modern thoracic endo-
vascular aortic repair (TEVAR) methods may complement
or replace conventional open SAA repair.
Methods: A retrospective review was performed of all
intra-thoracic SAAs repaired at a single institution since the
FDA approval of TEVAR in 2005.
Results: Nineteen patients underwent 20 operations to
repair 22 (13 native, 9 aberrant) SAAs with an intra-thoracic
component (Table). Mean SAA diameter was 3.1 cm (range
1.6-6.0 cm). Median patient age was 62 years (range 24-80
years). Four patients (21%) had a connective tissue disorder
(two Loeys-Dietz, two Marfan). Overall, 8 (36%) SAAs were
repaired by open techniques and 14 (64%) via a TEVAR-
based approach. All TEVAR cases required proximal landing
zone in the aortic arch and revascularization of at least one
arch vessel in 11 patients (79%). Concomitant repair of asso-
ciated aortic pathology was performed in 10 patients with 12
(55%) subclavian aneurysms. Thirty day/in-hospital rates of
death, stroke, andpermanent paraplegia/paresiswere 5% (n
1), 5% (n  1), and 0%, respectively. Three (16%) patients
required delayed re-intervention, two for occluded bypass
grafts and one for type II endoleak at a mean follow-up of 28
23 months.
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